EP1987148A4 - De-differentiation of astrocytes into neural stem cell using bmi-1 - Google Patents

De-differentiation of astrocytes into neural stem cell using bmi-1

Info

Publication number
EP1987148A4
EP1987148A4 EP06732855A EP06732855A EP1987148A4 EP 1987148 A4 EP1987148 A4 EP 1987148A4 EP 06732855 A EP06732855 A EP 06732855A EP 06732855 A EP06732855 A EP 06732855A EP 1987148 A4 EP1987148 A4 EP 1987148A4
Authority
EP
European Patent Office
Prior art keywords
astrocytes
bmi
differentiation
stem cell
neural stem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06732855A
Other languages
German (de)
French (fr)
Other versions
EP1987148A1 (en
Inventor
Seungkwon You
Jai Hee Moon
Byung Sun Yoon
Seung Jun Yoo
Ki Dong Kim
Isaac Maeng
Gyuman Park
Eun Kyung Jun
Sung Sik Kwak
Bona Kim
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IMGEN CO Ltd
Original Assignee
IMGEN CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IMGEN CO Ltd filed Critical IMGEN CO Ltd
Publication of EP1987148A1 publication Critical patent/EP1987148A1/en
Publication of EP1987148A4 publication Critical patent/EP1987148A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0618—Cells of the nervous system
    • C12N5/0623—Stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/20—Transition metals
    • C12N2500/24—Iron; Fe chelators; Transferrin
    • C12N2500/25—Insulin-transferrin; Insulin-transferrin-selenium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/11—Epidermal growth factor [EGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C12N2501/392—Sexual steroids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/60—Transcription factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/08—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from cells of the nervous system
EP06732855A 2006-02-27 2006-04-12 De-differentiation of astrocytes into neural stem cell using bmi-1 Withdrawn EP1987148A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20060019018 2006-02-27
PCT/KR2006/001350 WO2007097494A1 (en) 2006-02-27 2006-04-12 De-differentiation of astrocytes into neural stem cell using bmi-1

Publications (2)

Publication Number Publication Date
EP1987148A1 EP1987148A1 (en) 2008-11-05
EP1987148A4 true EP1987148A4 (en) 2009-08-05

Family

ID=38437522

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06732855A Withdrawn EP1987148A4 (en) 2006-02-27 2006-04-12 De-differentiation of astrocytes into neural stem cell using bmi-1

Country Status (5)

Country Link
EP (1) EP1987148A4 (en)
JP (1) JP2009528050A (en)
KR (1) KR100844971B1 (en)
CN (1) CN101389761A (en)
WO (1) WO2007097494A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8129187B2 (en) 2005-12-13 2012-03-06 Kyoto University Somatic cell reprogramming by retroviral vectors encoding Oct3/4. Klf4, c-Myc and Sox2
EP4223769A3 (en) 2005-12-13 2023-11-01 Kyoto University Nuclear reprogramming factor
US8278104B2 (en) 2005-12-13 2012-10-02 Kyoto University Induced pluripotent stem cells produced with Oct3/4, Klf4 and Sox2
JP2008307007A (en) 2007-06-15 2008-12-25 Bayer Schering Pharma Ag Human pluripotent stem cell induced from human tissue-originated undifferentiated stem cell after birth
US9213999B2 (en) 2007-06-15 2015-12-15 Kyoto University Providing iPSCs to a customer
US9683232B2 (en) 2007-12-10 2017-06-20 Kyoto University Efficient method for nuclear reprogramming
KR101532442B1 (en) 2007-12-10 2015-06-29 고쿠리츠 다이가쿠 호진 교토 다이가쿠 Efficient method for nuclear reprogramming
EP2242838A1 (en) * 2007-12-17 2010-10-27 GliaMed, Inc. Stem-like cells and method for reprogramming adult mammalian somatic cells
EP2268809B1 (en) 2008-05-02 2019-02-06 Kyoto University Method of nuclear reprogramming
AU2010312240B2 (en) 2009-10-31 2016-12-15 Genesis Technologies Limited Methods for reprogramming cells and uses thereof
US9453205B2 (en) 2009-10-31 2016-09-27 Genesis Technologies Limited Methods for reprogramming cells and uses thereof
KR101158402B1 (en) * 2009-12-30 2012-06-22 주식회사 일진케이제이 Generation composition for induced pluripotent stem cells with Bmi1 and Oct4, and method of manufacturing induced pluripotent stem cells using the same
JP2011135864A (en) 2009-12-30 2011-07-14 Korea Univ Research & Business Foundation Composition for retrodifferentiating somatic cell to embryonic stem cell-like cell, by using oct4 in combination with bmi1 or upstream regulator thereof, and method for generating embryonic stem cell-like cell using the same
CN102242146B (en) * 2010-05-10 2015-11-25 高丽大学校产学协力团 Composition and the method with its generation generate induced pluripotent stem cells
CN106381280B (en) 2010-05-13 2020-08-04 加州大学董事会 Methods and compositions for inducing human pluripotent stem cells
CN106754728B (en) * 2016-12-30 2020-05-15 中国人民解放军总医院 Metanephric mesenchymal cell line and preparation method and application thereof
CN109674809B (en) * 2018-12-27 2022-08-09 吉林大学 Composition containing miR-124-3P and application thereof in medicine for inducing neuron formation

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030022375A1 (en) * 2001-07-05 2003-01-30 Akira Itoh Vector for reversible gene integration

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19516776A1 (en) * 1995-05-10 1996-11-14 Boehringer Ingelheim Int Chromatin regulatory genes
US6897061B1 (en) * 2000-06-16 2005-05-24 Spinal Cord Society Transdifferentiation of glial cells
US6919204B2 (en) * 2000-09-29 2005-07-19 Sangamo Biosciences, Inc. Modulation of gene expression using localization domains
KR20010099203A (en) * 2001-09-11 2001-11-09 이상훈 Method for differentiation of neural stem cell to dopaminergic neuron

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030022375A1 (en) * 2001-07-05 2003-01-30 Akira Itoh Vector for reversible gene integration

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
ALKEMA M J ET AL: "CHARACTERIZATION AND CHROMOSOMAL LOCALIZATION OF THE HUMAN PROTO-ONCOGENE BMI-1", HUMAN MOLECULAR GENETICS, OXFORD UNIVERSITY PRESS, SURREY, vol. 2, no. 10, 1 October 1993 (1993-10-01), pages 1597 - 1603, XP000676533, ISSN: 0964-6906 *
JOANNIDES ALEXIS ET AL: "Efficient generation of neural precursors from adult human skin: astrocytes promote neurogenesis from skin-derived stem cells.", LANCET 2004 JUL 10-16, vol. 364, no. 9429, 10 July 2004 (2004-07-10), pages 172 - 178, XP002533122, ISSN: 1474-547X *
MOLOFSKY A V ET AL: "Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation", NATURE, NATURE PUBLISHING GROUP, LONDON, UK, vol. 425, no. 6961, 30 October 2003 (2003-10-30), pages 962 - 967, XP002324138, ISSN: 0028-0836 *
MOON J H ET AL: "Induction of neural stem cell-like cells (NSCLCs) from mouse astrocytes by Bmi1", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 371, no. 2, 27 June 2008 (2008-06-27), pages 267 - 272, XP022659023, ISSN: 0006-291X, [retrieved on 20080424] *
PARK IN-KYUNG ET AL: "Bmi1, stem cells, and senescence regulation.", THE JOURNAL OF CLINICAL INVESTIGATION JAN 2004, vol. 113, no. 2, January 2004 (2004-01-01), pages 175 - 179, XP002533123, ISSN: 0021-9738 *
See also references of WO2007097494A1 *
ZENCAK DUSAN ET AL: "Bmi1 loss produces an increase in astroglial cells and a decrease in neural stem cell population and proliferation.", THE JOURNAL OF NEUROSCIENCE : THE OFFICIAL JOURNAL OF THE SOCIETY FOR NEUROSCIENCE 15 JUN 2005, vol. 25, no. 24, 15 June 2005 (2005-06-15), pages 5774 - 5783, XP002533121, ISSN: 1529-2401 *

Also Published As

Publication number Publication date
KR20070089089A (en) 2007-08-30
JP2009528050A (en) 2009-08-06
CN101389761A (en) 2009-03-18
EP1987148A1 (en) 2008-11-05
KR100844971B1 (en) 2008-07-09
WO2007097494A1 (en) 2007-08-30

Similar Documents

Publication Publication Date Title
EP1987148A4 (en) De-differentiation of astrocytes into neural stem cell using bmi-1
IL283597A (en) Feeder-free pluripotent stem cell media containing human serum
ZA201606403B (en) Pluripotent stem cell culture on micro-carriers
PL2046946T3 (en) Pluripotent stem cell culture
HK1219295A1 (en) Derivation of embryonic stem cells
GB2458863B (en) Improved culture of stem cells
GB2432835B (en) Culturing human embryonic stem cells
EP2315829A4 (en) Induced pluripotent stem cells
GB0710095D0 (en) Culture method of stem cell
EP2283117A4 (en) Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells
ZA201000715B (en) Single pluripotent stem cell culture
EP2155859A4 (en) Formulations and methods for culturing embryonic stem cells
SG138570A1 (en) Growth of embryonic stem cells
IL178232A0 (en) Methods for growing pluripotent stem cells
GB201005548D0 (en) Neural tumor stem cells and methods of use thereof
GB0901623D0 (en) Method for stem cell culture and cells derived therefrom
EP2487236A4 (en) Culture substratum for human pluripotent stem cells, and use thereof
EP1991666A4 (en) Non-embryonic totipotent blastomere-like stem cells and methods therefor
EP2028264A4 (en) Cell incubator
EP2007411A4 (en) Regulating stem cells
GB2460552B (en) Stem cell culture media and methods
WO2009093022A3 (en) Cell re-programming
EP2021464A4 (en) Method for culturing human embryonic stem cells
EP1993477A4 (en) Transplantation of neural cells
HK1147218A1 (en) Stem cell lines, their application and culture methods

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20080822

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

A4 Supplementary search report drawn up and despatched

Effective date: 20090706

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090924